Literature DB >> 10896918

Association of aldehyde dehydrogenase 2 gene polymorphism with multiple oesophageal dysplasia in head and neck cancer patients.

M Muto1, Y Hitomi, A Ohtsu, S Ebihara, S Yoshida, H Esumi.   

Abstract

BACKGROUND: Multiple occurrences of oesophageal dysplasia are frequently observed in head and neck cancer patients, and closely associated with alcohol consumption. Acetaldehyde, the first metabolite of ethanol, is thought to play an important role in the carcinogenesis of the upper aerodigestive tract. AIM: To investigate if genetic polymorphism in alcohol metabolising enzymes (ADH3, alcohol dehydrogenase 3; ALDH2, aldehyde dehydrogenase 2) is associated with oesophageal multiple dysplasia in head and neck cancer patients.
METHODS: Thirty one consecutive patients with head and neck cancer were included in the study. Multiple oesophageal dysplasia was detected endoscopically as multiple Lugol voiding lesions (multiple LVL) using the Lugol dye staining method. The ADH3 and ALDH2 genotypes were determined by polymerase chain reaction-restriction fragment length polymorphism.
RESULTS: Among the 31 patients with head and neck cancer, 17 had multiple LVL. Multiple LVL were closely associated with a second primary oesophageal carcinoma in head and neck cancer patients (odds ratio 60.7, 95% CI 5.6-659). Furthermore, the mutant ALDH2 allele was significantly more prevalent in patients with multiple LVL (65% v 29%; p<0.05) whereas no difference was observed in ADH3 polymorphism.
CONCLUSIONS: The mutant ALDH2 allele appears to be a risk indicator for multiple LVL in head and neck cancer patients. Accumulation of acetaldehyde due to low ALDH2 activity may play a critical role in cancerous changes throughout the mucosa in the upper aerodigestive tract.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10896918      PMCID: PMC1727996          DOI: 10.1136/gut.47.2.256

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  25 in total

1.  Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin.

Authors:  D P SLAUGHTER; H W SOUTHWICK; W SMEJKAL
Journal:  Cancer       Date:  1953-09       Impact factor: 6.860

2.  Lugol staining pattern and histology of esophageal lesions.

Authors:  M Mori; Y Adachi; T Matsushima; H Matsuda; H Kuwano; K Sugimachi
Journal:  Am J Gastroenterol       Date:  1993-05       Impact factor: 10.864

Review 3.  Genetics of human alcohol and aldehyde dehydrogenases.

Authors:  M Smith
Journal:  Adv Hum Genet       Date:  1986

4.  Alcohol and aldehyde dehydrogenases in human esophagus: comparison with the stomach enzyme activities.

Authors:  S J Yin; F J Chou; S F Chao; S F Tsai; C S Liao; S L Wang; C W Wu; S C Lee
Journal:  Alcohol Clin Exp Res       Date:  1993-04       Impact factor: 3.455

5.  Liver alcohol dehydrogenase and aldehyde dehydrogenase in the Japanese: isozyme variation and its possible role in alcohol intoxication.

Authors:  S Harada; S Misawa; D P Agarwal; H W Goedde
Journal:  Am J Hum Genet       Date:  1980-01       Impact factor: 11.025

6.  Improved methods for genotype determination of human alcohol dehydrogenase (ADH) at ADH 2 and ADH 3 loci by using polymerase chain reaction-directed mutagenesis.

Authors:  A Groppi; J Begueret; A Iron
Journal:  Clin Chem       Date:  1990-10       Impact factor: 8.327

7.  Endoscopic screening of early esophageal cancer with the Lugol dye method in patients with head and neck cancers.

Authors:  H Shiozaki; H Tahara; K Kobayashi; H Yano; S Tamura; H Imamoto; T Yano; K Oku; M Miyata; K Nishiyama
Journal:  Cancer       Date:  1990-11-15       Impact factor: 6.860

Review 8.  Genetic polymorphism of human liver alcohol and aldehyde dehydrogenases, and their relationship to alcohol metabolism and alcoholism.

Authors:  W F Bosron; T K Li
Journal:  Hepatology       Date:  1986 May-Jun       Impact factor: 17.425

Review 9.  Pharmacogenetics of alcohol metabolism and alcoholism.

Authors:  D P Agarwal; H W Goedde
Journal:  Pharmacogenetics       Date:  1992-04

10.  Genetic polymorphism of alcohol and aldehyde dehydrogenase and the effects on alcohol metabolism.

Authors:  K Yamamoto; Y Ueno; Y Mizoi; Y Tatsuno
Journal:  Arukoru Kenkyuto Yakubutsu Ison       Date:  1993-02
View more
  21 in total

1.  Impairment of aldehyde dehydrogenase 2 increases accumulation of acetaldehyde-derived DNA damage in the esophagus after ethanol ingestion.

Authors:  Yoshiyuki Yukawa; Shinya Ohashi; Yusuke Amanuma; Yukie Nakai; Mihoko Tsurumaki; Osamu Kikuchi; Shin'ichi Miyamoto; Tsunehiro Oyama; Toshihiro Kawamoto; Tsutomu Chiba; Tomonari Matsuda; Manabu Muto
Journal:  Am J Cancer Res       Date:  2014-05-26       Impact factor: 6.166

2.  Esophageal melanosis, an endoscopic finding associated with squamous cell neoplasms of the upper aerodigestive tract, and inactive aldehyde dehydrogenase-2 in alcoholic Japanese men.

Authors:  Akira Yokoyama; Tai Omori; Tetsuji Yokoyama; Yoichi Tanaka; Takeshi Mizukami; Sachio Matsushita; Susumu Higuchi; Hisao Takahashi; Katsuya Maruyama; Hiromasa Ishii; Toshifumi Hibi
Journal:  J Gastroenterol       Date:  2005-07       Impact factor: 7.527

3.  Association between macrocytosis and metachronous squamous cell carcinoma of the esophagus after endoscopic resection in men with early esophageal squamous cell carcinoma.

Authors:  Chikatoshi Katada; Tetsuji Yokoyama; Tomonori Yano; Ichiro Oda; Yuichi Shimizu; Hisashi Doyama; Tomoyuki Koike; Kohei Takizawa; Motohiro Hirao; Hiroyuki Okada; Takako Yoshii; Yutaro Kubota; Takenori Yamanouchi; Takashi Tsuda; Tai Omori; Nozomu Kobayashi; Haruhisa Suzuki; Satoshi Tanabe; Keisuke Hori; Norisuke Nakayama; Hirofumi Kawakubo; Naomi Kakushima; Yasumasa Matsuo; Hideki Ishikawa; Akira Yokoyama; Manabu Muto
Journal:  Esophagus       Date:  2019-07-08       Impact factor: 4.230

Review 4.  Post-translational modifications of mitochondrial aldehyde dehydrogenase and biomedical implications.

Authors:  Byoung-Joon Song; Mohamed A Abdelmegeed; Seong-Ho Yoo; Bong-Jo Kim; Sangmee A Jo; Inho Jo; Kwan-Hoon Moon
Journal:  J Proteomics       Date:  2011-05-15       Impact factor: 4.044

Review 5.  Alcohol drinking, cigarette smoking, and the development of squamous cell carcinoma of the esophagus: epidemiology, clinical findings, and prevention.

Authors:  Masaru Morita; Ryuichi Kumashiro; Nobuhide Kubo; Yuichiro Nakashima; Rintaro Yoshida; Keiji Yoshinaga; Hiroshi Saeki; Yasunori Emi; Yoshihiro Kakeji; Yoshihisa Sakaguchi; Yasushi Toh; Yoshihiko Maehara
Journal:  Int J Clin Oncol       Date:  2010-03-12       Impact factor: 3.402

6.  Human ALDH1B1 polymorphisms may affect the metabolism of acetaldehyde and all-trans retinaldehyde--in vitro studies and computational modeling.

Authors:  Brian C Jackson; Philip Reigan; Bettina Miller; David C Thompson; Vasilis Vasiliou
Journal:  Pharm Res       Date:  2014-11-21       Impact factor: 4.200

Review 7.  Non-P450 aldehyde oxidizing enzymes: the aldehyde dehydrogenase superfamily.

Authors:  Satori A Marchitti; Chad Brocker; Dimitrios Stagos; Vasilis Vasiliou
Journal:  Expert Opin Drug Metab Toxicol       Date:  2008-06       Impact factor: 4.481

Review 8.  Aldehyde dehydrogenases in cellular responses to oxidative/electrophilic stress.

Authors:  Surendra Singh; Chad Brocker; Vindhya Koppaka; Ying Chen; Brian C Jackson; Akiko Matsumoto; David C Thompson; Vasilis Vasiliou
Journal:  Free Radic Biol Med       Date:  2012-11-27       Impact factor: 7.376

Review 9.  The role of ALDH2 in tumorigenesis and tumor progression: Targeting ALDH2 as a potential cancer treatment.

Authors:  Hong Zhang; Liwu Fu
Journal:  Acta Pharm Sin B       Date:  2021-02-11       Impact factor: 11.413

10.  Telomere shortening in the esophagus of Japanese alcoholics: relationships with chromoendoscopic findings, ALDH2 and ADH1B genotypes and smoking history.

Authors:  Junko Aida; Akira Yokoyama; Naotaka Shimomura; Ken-ichi Nakamura; Naoshi Ishikawa; Masanori Terai; Steven Poon; Masaaki Matsuura; Mutsunori Fujiwara; Motoji Sawabe; Tomio Arai; Kaiyo Takubo
Journal:  PLoS One       Date:  2013-05-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.